Pyridoxal 5'-phosphate and Risk of Stroke: Triangulation of Evidence from a Nationally Representative Cohort and Bidirectional Mendelian Randomization Analysis

Overview

Journal EPMA J

Date 2025 Feb 24

PMID 39991095

Authors

Mengqi Zhang

Jiani Zhong

Yanyi Peng

Lingjia Hao

Bo Xiao

Affiliations

Soon will be listed here.

Abstract

Background: Stroke is a leading cause of mortality and disability worldwide. Identifying predictive biomarkers and modifiable risk factors is crucial for stroke prevention in the context of predictive, preventive, and personalized medicine (PPPM). We aimed to investigate the association of serum pyridoxal 5'-phosphate (PLP) levels with stroke prevalence in a nationally representative cohort and to assess the causal relationship using bidirectional Mendelian randomization (MR) analysis, with a focus on the implications for PPPM strategies in stroke management.

Methods: We included 6839 participants aged ≥ 18 years from the National Health and Nutrition Examination Survey (NHANES) 2005-2013. Serum PLP levels were measured by high-performance liquid chromatography. Stroke prevalence was ascertained by self-report. We used generalized linear models, Kaplan-Meier curves, restricted cubic splines, stratified analysis, receiver operating characteristic (ROC) curves, and bidirectional two-sample MR to examine the association of PLP levels with stroke prevalence and assess the causal relationship.

Results: In the fully adjusted model, participants with low serum PLP levels had significantly higher odds of stroke compared to those with high levels (odds ratio (OR) = 6.51e-01, 95% confidence interval (CI) 4.46e-01-9.50e-01, = 2.74E-02). Kaplan-Meier curves showed significantly lower survival probability in the low PLP group ( < 0.05). The restricted cubic spline analysis revealed a non-linear association, with the highest stroke risk at lower PLP levels. The stratified analysis showed significant associations in several subgroups. The ROC analysis indicated good predictive performance of the fully adjusted model (area under the curve (AUC) > 0.7). The MR analysis supported a protective causal effect of PLP on stroke risk (OR = 0.7723581, 95% CI 0.6388086-0.9336201, = 0.00345), while the reverse MR analysis did not suggest a causal effect of stroke on PLP levels.

Conclusions: Low serum PLP levels are significantly associated with higher stroke prevalence in a nationally representative the United States (US) sample. Integration of observational and genetic evidence supports a protective causal role of PLP in stroke risk. Serum PLP may serve as a promising predictive biomarker for stroke risk assessment and a potential target for personalized nutritional interventions in stroke prevention, in line with PPPM strategies. Our findings highlight the importance of maintaining optimal vitamin B6 status for effective PPPM-guided stroke prevention and management.

Supplementary Information: The online version contains supplementary material available at 10.1007/s13167-024-00392-2.

References

Carter A, Sanderson E, Hammerton G, Richmond R, Davey Smith G, Heron J . Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021; 36(5):465-478. PMC: 8159796. DOI: 10.1007/s10654-021-00757-1. View

Feigin V, Brainin M, Norrving B, Martins S, Sacco R, Hacke W . World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. Int J Stroke. 2022; 17(1):18-29. DOI: 10.1177/17474930211065917. View

Minovic I, Kieneker L, Gansevoort R, Eggersdorfer M, Touw D, Voerman A . Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study. Nutrients. 2020; 12(9). PMC: 7551483. DOI: 10.3390/nu12092711. View

Yuan S, Mason A, Carter P, Burgess S, Larsson S . Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study. BMC Med. 2021; 19(1):97. PMC: 8063383. DOI: 10.1186/s12916-021-01977-8. View

Shah A, Dhalla N . Effectiveness of Some Vitamins in the Prevention of Cardiovascular Disease: A Narrative Review. Front Physiol. 2021; 12:729255. PMC: 8531219. DOI: 10.3389/fphys.2021.729255. View

Israr M, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney L . Association of gut-related metabolites with outcome in acute heart failure. Am Heart J. 2021; 234:71-80. DOI: 10.1016/j.ahj.2021.01.006. View

Mughram M, Ghatge M, Kellogg G, Safo M . Elucidating the Interaction between Pyridoxine 5'-Phosphate Oxidase and Dopa Decarboxylase: Activation of B6-Dependent Enzyme. Int J Mol Sci. 2023; 24(1). PMC: 9820991. DOI: 10.3390/ijms24010642. View

Ali M, Hafez H, Kamel M, Ghamry H, Shukry M, Farag M . Dietary Vitamin B Complex: Orchestration in Human Nutrition throughout Life with Sex Differences. Nutrients. 2022; 14(19). PMC: 9573099. DOI: 10.3390/nu14193940. View

Bisello G, Ribeiro R, Perduca M, Belviso B, Polverino de Laureto P, Giorgetti A . Human aromatic amino acid decarboxylase is an asymmetric and flexible enzyme: Implication in aromatic amino acid decarboxylase deficiency. Protein Sci. 2023; 32(8):e4732. PMC: 10382914. DOI: 10.1002/pro.4732. View

10.

Bowman K, Jones L, Pilling L, Delgado J, Kuchel G, Ferrucci L . Vitamin D levels and risk of delirium: A mendelian randomization study in the UK Biobank. Neurology. 2019; 92(12):e1387-e1394. PMC: 6511096. DOI: 10.1212/WNL.0000000000007136. View

11.

Kato N, Kimoto A, Zhang P, Bumrungkit C, Karunaratne S, Yanaka N . Relationship of Low Vitamin B6 Status with Sarcopenia, Frailty, and Mortality: A Narrative Review. Nutrients. 2024; 16(1). PMC: 10780671. DOI: 10.3390/nu16010177. View

12.

Fay M, Proschan M . Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat Surv. 2010; 4:1-39. PMC: 2857732. DOI: 10.1214/09-SS051. View

13.

Mascolo E, Verni F . Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms. Int J Mol Sci. 2020; 21(10). PMC: 7279184. DOI: 10.3390/ijms21103669. View

14.

Wilson M, Plecko B, Mills P, Clayton P . Disorders affecting vitamin B metabolism. J Inherit Metab Dis. 2019; 42(4):629-646. DOI: 10.1002/jimd.12060. View

15.

Ueland P, Ulvik A, Rios-Avila L, Midttun O, Gregory J . Direct and Functional Biomarkers of Vitamin B6 Status. Annu Rev Nutr. 2015; 35:33-70. PMC: 5988249. DOI: 10.1146/annurev-nutr-071714-034330. View

16.

Kintu C, Soremekun O, Kamiza A, Kalungi A, Mayanja R, Kalyesubula R . The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study. EBioMedicine. 2023; 90:104537. PMC: 10070509. DOI: 10.1016/j.ebiom.2023.104537. View

17.

Weikert C, Dierkes J, Hoffmann K, Berger K, Drogan D, Klipstein-Grobusch K . B vitamin plasma levels and the risk of ischemic stroke and transient ischemic attack in a German cohort. Stroke. 2007; 38(11):2912-8. DOI: 10.1161/STROKEAHA.107.486068. View

18.

Zhang N, Wu Z, Bai X, Song Y, Li P, Lu X . Dosage exploration of combined B-vitamin supplementation in stroke prevention: a meta-analysis and systematic review. Am J Clin Nutr. 2024; 119(3):821-828. DOI: 10.1016/j.ajcnut.2023.12.021. View

19.

Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T . Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023; 14(1):21-42. PMC: 9971534. DOI: 10.1007/s13167-023-00314-8. View

20.

Zhang P, Xie X, Zhang Y . Associations between homocysteine and B vitamins and stroke: a cross-sectional study. Front Neurol. 2023; 14:1184141. PMC: 10339286. DOI: 10.3389/fneur.2023.1184141. View